About Index Trending news
Analyze
Pricing
Cerevast

Cerevast

Cerevast

Cerevast Therapeutics is a medical technology company developing treatments for acute ischemic stroke and other vascular disorders.
I work here Suggest edits
More info

Elsewhere

Contributors to this profile

Companies in the same industry

Extrakt Chemie Extrakt Chemie BioMedical Enterprises BioMedical Enterprises CORPAK MedSystems, Inc. CORPAK MedSystems, Inc. TENSIVE TENSIVE OncoResponse OncoResponse Avivagen Inc. Avivagen Inc. Algaeon, Inc. Algaeon, Inc. Aclaris Therapeutics, Inc. Aclaris Therapeutics, Inc. RODO Medical RODO Medical Labster Labster

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 6
Add info
Latest funding Show all
Venture capital
$10,000,000
Debt financing
$1,780,000
Employees

Team size

10+
Locations
HQ
United States
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Cerevast makes some noise.